|
KR20180080433A
|
|
Novel Polymorphic DH Form of Aripiprazole Anhydride and Preparing Method of the Same
|
|
KR20180066454A
|
|
Preparing Method of Silodosin in β Crystal Form
|
|
KR20160000993A
|
|
Crystalline Form of Sarpogrelate Oxalate Monohydrate or Sarpogrelate Oxalate Anhydride
|
|
KR20150010128A
|
|
Process for preparing crystalline form ii of sarpogrelate hydrochloride
|
|
KR20140140334A
|
|
Novel Organic Acid Addition Salts of Lamivudine and Process for Preparing Them
|
|
KR20140075524A
|
|
Improved Process for Preparing Lamivudine
|
|
KR20120107791A
|
|
Process for preparing 5-(4-alkylpiperazinylsulfonylphenyl)-pyrazolo[4,3-d]pyrimidin-7-one derivatives
|
|
KR20120000754A
|
|
Process for preparing crystalline form i of donepezil hydrochloride salt
|
|
KR20110115343A
|
|
Crystalline bepotastine nicotinic acid and the preparation thereof
|
|
KR20110115342A
|
|
Crystalline bepotastine salicylic acid and the preparation thereof
|
|
KR20110001415A
|
|
New synthetic method of 4,4,4-trifluoro-1-(4-methylphenyl) butane-1,3-dione
|
|
KR20100136112A
|
|
New method for preparing capecitabine and new benzothiazole derivatives
|
|
KR20100113227A
|
|
New intermediate of lamivudine and the preparation thereof
|
|
KR20100108113A
|
|
Adefovir dipivoxil dh-type crystalline form, preparing method thereof, and pharmaceutical composition for antivirus agent containing them
|
|
KR20100093705A
|
|
New preparation of intermediates of pemetrexed
|
|
KR20100088870A
|
|
New process for 3,4-dihydroquinazolin-4-one derivatives
|
|
KR20100088992A
|
|
(r)-sibutramine salts and the preparation thereof
|
|
KR20100084035A
|
|
New method for preparing pyrazole derivatives
|
|
KR20100070908A
|
|
Process for preparing valsartan methyl ester
|
|
KR20100038695A
|
|
The new preparation of adeforvir dipivoxil
|
